Mountain View, United States
Sentieon, founded in 2014, is a promising player in the Biotechnology and Clean Energy sectors, based in the United States. The company excels in enhancing the efficiency of bioinformatics tools, aiming to support scientists, clinicians, patients, and consumers in utilizing precise genomic information. This mission addresses the increasing demand for accuracy in genomic data interpretation, positioning them at the forefront of bioinformatics innovation.
The company's growth momentum is underscored by a successful $20.00M Series B funding round completed on 25 May 2015. This round saw participation from prominent investors including Oriza Ventures, Amino Capital, IDG Capital, Centana Growth Partners, SV Tech Ventures, Ten Coves Capital, and CLI Ventures. Their investment highlights strong confidence in Sentieon's potential and its cutting-edge solutions.
